Loomis, Sayles & Company’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-661
| Closed | -$4K | – | 872 |
|
|
2023
Q4 | $4K | Sell |
661
-89
| -12% | -$539 | ﹤0.01% | 910 |
|
|
2023
Q3 | $8K | Buy |
750
+396
| +112% | +$4.22K | ﹤0.01% | 842 |
|
|
2023
Q2 | $4K | Sell |
354
-1,266
| -78% | -$14.3K | ﹤0.01% | 887 |
|
|
2023
Q1 | $23K | Buy |
+1,620
| New | +$23K | ﹤0.01% | 720 |
|
|
2022
Q4 | – | Sell |
-79
| Closed | -$2K | – | 940 |
|
|
2022
Q3 | $2K | Hold |
79
| – | – | ﹤0.01% | 821 |
|
|
2022
Q2 | $2K | Hold |
79
| – | – | ﹤0.01% | 857 |
|
|
2022
Q1 | $3K | Buy |
+79
| New | +$3K | ﹤0.01% | 880 |
|
|
2021
Q4 | – | Sell |
-231
| Closed | -$11K | – | 857 |
|
|
2021
Q3 | $11K | Buy |
+231
| New | +$11K | ﹤0.01% | 788 |
|